Cancer Research

For lymphoma patients, particularly those facing relapsed or refractory large B cell lymphoma (LBCL), CAR T cell therapy represents a beacon of hope. This promising treatment, epitomized by Breyanzi (lisocabtagene maraleucel), offers a new avenue for those who have exhausted conventional treatment

Cervical cancer, despite being largely preventable, continues to claim the lives of two women in the UK every day—a stark reminder of the ongoing battle against the disease. In a bid to change this grim statistic, NHS England has committed to an ambitious goal of eliminating cervical cancer by 2

Aging is a complex biological process that affects various cellular functions, including the behavior of stem cells. Recent research has shed light on how aging impacts iron homeostasis in lung stem cells, leading to a reduction in their tumorigenic potential. This article delves into the intricate

In a strategic move to tackle severe blood cancers, Alanis Therapeutics (ATI) has teamed up with KBI Biopharma to enhance the development and manufacturing of ATI's preclinical antibody candidate, ATI-D1. This partnership aims to accelerate the treatment of myelodysplastic syndromes (MDS) and

In a groundbreaking move aiming to reshape the process of diagnosing colorectal cancer, the Community Diagnostic Centre (CDC) in Telford has launched a £1 million research study known as TRIOMIC. This innovative study is designed to significantly shorten the anxiety-inducing waiting period for a

The study conducted by Linda Lindström and her team at Karolinska Institutet delves into the significant role menopausal status plays in the long-term efficacy of tamoxifen, an anti-hormonal treatment for estrogen-sensitive breast cancer. Published in the Journal of the National Cancer Institute